中国商报（记者 于佳鑫 文/图）华灯初上之时，北京的夜晚褪去白日的忙碌，化作消费与活力交织的"第二战场"。从丰台花街的"左手鲜花，右手烟火气"到 什刹海的桨声灯影，从"丽泽怪市"的潮玩文化到月亮河夜市的河畔风情，京城的夏夜经济正以多元形态迸发生机。 夜市中的"烟火人间" "我们从下午5点左右就过来摆摊，一直摆到晚上11点左右。"在北京丰台花街夜市，一名摊主告诉记者。 这名摊主卖的是自家种植的有机西红柿，价格5元一斤。鲜红的色泽、饱满的果实，吸引不少夜市游客的目光。她告诉记者，自己最近几天刚刚过来摆摊， 因为连日来生意不错，感到很开心。 苏工和田行五 and and a 这样鲜活的商业图景，每天都在花街夜市上演。花街夜市依托北京花卉交易中心的地理位置，全长约700米，如今已汇聚了数十家特色摊位，涵盖小吃、酒 水、果蔬、手作等多元业态。 丰台花街夜市上的甜品摊位。 花街夜市招商负责人向记者介绍，夜市目前采取"差异化招商"的策略，确保各个摊位业态互补、特色鲜明。在夜市现场，记者看到，这里有新疆烤串、大连 焖子等地方特色美食，也不乏手工榴莲饼、精酿啤酒、鲜榨果汁等网红小吃和饮料，还有动漫周边、精美手作等文创潮品。此外 ...

近日，IDC发布2025年第一季度全球智能手机市场数据显示，尽管行业整体仍面临周期性调整压力，但 联想摩托罗拉在全球智能手机市场持续展现出强劲的突围势头，联想摩托罗拉在日本市场出货量暴增 307.0%，在巴西市场位居第二。 市场分析认为，随着AI技术的应用，高端市场发展以及本地化生产等因素正推动市场正向增长。 这一数据，是摩托罗拉产品力、市场策略与用户需求精准契合的有力证明。根据此前公开数据报道， 2025年一季度，联想摩托罗拉在除中国以外的海外市场收入达到34.2亿美元，同比增长16.7%，远超市 场4.4%的增速。市场份额也从第五位升至第四位，超越OPPO、传音和谷歌。在全球市场中，联想以 2.5%的收入份额位列第八，同比提升0.3个百分点，增速16.4%远超行业4.3%的平均水平。 北美市场和亚太新兴市场是两大核心增长极，其中：北美市场收入10.1亿美元，同比增长20.4%，份额 3.6%排名第四；美国市场收入9.9亿美元，排名从第四升至第三。亚太新兴市场营收更是创下同比92.1% 的超高速增长。 在全球智能手机市场步入存量博弈的关键阶段，竞争愈发白热化。联想凭借深厚的品牌积淀与源源不断 的创新动能，成 ...

New Stock Listings - Guangxin Technology (Stock Code: 920037) listed at an issuance price of 10.00[1] Equity Offers - Jichuan Pharmaceutical (Stock Code: 600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - ST Yazhen (Stock Code: 603389) has a tender offer period from June 10, 2025, to July 9, 2025[1] - ST Zhongcheng (Stock Code: 300208) enters delisting arrangement starting June 30, 2025[1] - ST Jinguang (Stock Code: 600190) enters delisting arrangement starting June 30, 2025[1] - Hengli (Stock Code: 000622) has 13 trading days remaining until the last trading day[1] - Delisting Jiuyou (Stock Code: 600462) has 12 trading days remaining until the last trading day[1] Trading Alerts - ST Longyu (Stock Code: 603003) has 2 trading days remaining until the last trading day[1] - ST Pengbo (Stock Code: 600804) has 2 trading days remaining until the last trading day[1] - Longjin (Stock Code: 002750) has its last trading day on June 26, 2025[1] Significant Price Fluctuations - Tongyuan Petroleum (Stock Code: 300164) reported significant price fluctuations[1] - Jinshi Technology (Stock Code: 002951) reported significant price fluctuations[1] - Huilong Co., Ltd. (Stock Code: 002556) reported significant price fluctuations[1]

Fiscal Fourth Quarter Results August 22, 2019 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes "forward-looking statements" within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include all statements that do not relate solely to historical or current facts, and you can identify forward-looking statements because they contain words such as "believes," "expects," "may," "will," "outlook," "should," "seeks," "i ...

Fourth Quarter & Full-Year Fiscal 2020 Results August 20, 2020 DISCLAIMER Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes "forward-looking statements" within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include all statements that do not relate solely to historical or current facts, and you can identify forward-looking statements because they contain words such as "believes," "expects," "may," "will," "out ...

Fourth Quarter & Fiscal year 2021 Results Conference Call August 19, 2021 (发 DISCLAIMER This presentation contains "forward-looking statements"—that is, statements related to future events within the meaning of the Private Securities Litigation Reform Act of 1995. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements. In this context, forward-looking statements often address our expected future business, financial performance, financial condition and resu ...

中国发展网讯 2025年6月24日，由中国人民大学深圳研究院〔社会科学高等研究院（深圳）〕主办，中 国人民大学国际货币研究所（IMI）、中国人民大学深圳金融高等研究院共同承办的"大金融思想沙龙 （第257期）暨人大深圳社科沙龙（总第63期）"在线上成功举行。 中国银行研究院院长陈卫东围绕"低利率时代金融机构的韧性重塑"进行了深入分析，特别是对银行业在 低利率环境下的应对策略提出了多项建议。 陈卫东还指出，金融机构必须积极拓展综合经营业务，扩大收入来源。他提到，除了传统的信贷业务 外，银行应加强债券承销、债券投资、理财、外汇市场等业务的布局，尤其是关注资本市场的变化，充 分利用市场波动带来的机会。他特别提到，国际化业务的拓展也是银行在低利率时期应对压力的重要方 式之一，通过调整国际资产组合，可以平抑国内经济下行周期带来的影响，增加银行的盈利空间。 最后，陈卫东强调，监管政策、考核机制可以更加注重有利于金融机构的差异化竞争。他认为，不同规 模和类型的金融机构面临的挑战各不相同，各自有不同的优势，如果能够根据不同机构的特色和优势适 当区分监管和考核指标，将有利于各机构在细分市场专业化发展。对一些业务给予市场化的定价 ...

在备受关注的圆桌论坛环节，由郭庆主持，氯碱协会执行会长宋祥东、滨化集团期货部部长靳圻、山东 博汇集团有限公司董办总监程晨、东营市赫邦化工有限公司市场运营部部长杜怀志、广东塑道化工控股 有限公司烧碱负责人马海杰等嘉宾共同参与讨论。各位嘉宾就氯碱产业当前面临的市场形势、期现结合 实践中的问题与经验、企业自身交割套保情况、行业未来发展趋势等话题各抒己见，展开了热烈的交流 与探讨。现场思维碰撞，气氛十分活跃，为参会者带来了诸多富有价值的观点和建议。 本次会议的成功举办，为氯碱行业搭建了一个交流合作的优质平台，促进了期现结合理念在氯碱产业中 的深入应用，对推动氯碱行业深度参与期货市场具有重要意义。未来，各方将继续携手努力，共同为氯 碱产业的繁荣发展贡献力量。 （文章来源：期货日报网） 山东省氯碱行业协会（以下简称氯碱协会）执行会长宋祥东发表了关于《氯碱绿色可持续发展简析》的 演讲。他深入剖析了当前氯碱行业上中下游产业链产品运行情况，并对环保、资源利用等相关政策进行 解析，强调了期货工具对于氯碱行业未来发展的重要性。 滨化集团氯碱研究员王敬涵以《期货工具赋能烧碱企业创新发展》为题，详细阐述了期货工具如何在风 险管理、价格 ...

Market Overview - The Shanghai Composite Index closed at 3448.45 points, remaining above the six-month moving average, with a slight decline of -0.22% [1] - The total trading volume of A-shares reached 16232.23 billion yuan [1] Stocks Breaking the Six-Month Moving Average - A total of 68 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - *ST Tianyu with a deviation rate of 9.89% and a daily increase of 13.30% [1] - Qujiang Cultural Tourism with a deviation rate of 8.50% and a daily increase of 10.02% [1] - Oriental Ocean with a deviation rate of 7.48% and a daily increase of 9.85% [1] Detailed Stock Performance - The following stocks have notable performance metrics: - *ST Tianyu: Latest price 4.60 yuan, six-month line 4.19 yuan, turnover rate 4.88% [1] - Qujiang Cultural Tourism: Latest price 10.54 yuan, six-month line 9.71 yuan, turnover rate 17.89% [1] - Oriental Ocean: Latest price 2.90 yuan, six-month line 2.70 yuan, turnover rate 15.91% [1] - Other stocks with smaller deviation rates include: - Huakong Saige with a deviation rate of 2.98% and a daily increase of 4.42% [1] - Adit with a deviation rate of 2.96% and a daily increase of 3.24% [1]

Core Viewpoint - Rongchang Biopharma has entered a significant partnership with Vor Bio, involving a $4.2 billion risk-sharing agreement and a $175 million private investment in public equity (PIPE) deal, aimed at advancing clinical product lines and addressing liquidity issues [2][3][5]. Group 1: Financial Transactions - Rongchang Biopharma will receive $1.25 billion in cash and warrants from Vor Bio, including a $45 million upfront payment and $800 million in warrants, along with potential milestone payments totaling up to $4.1 billion [5][6]. - Vor Bio plans to issue 700 million warrants at a price of $0.25 per share as part of the PIPE, with expected net proceeds to be used for clinical development and operational expenses [2][8]. Group 2: Company Strategies and Challenges - Vor Bio is shifting its focus to autoimmune disease treatments, particularly the drug Tai Itasip, which has received various regulatory recognitions in China and the U.S. [8][9]. - Despite the immediate financial relief from the PIPE, Vor Bio's long-term prospects remain uncertain due to previous operational challenges, including a significant workforce reduction and halted clinical trials [6][10]. Group 3: Market Reactions and Future Outlook - Analysts express caution regarding Vor Bio's ability to execute its clinical and commercialization strategies effectively, given its reduced team size and the need for potential partnerships to enhance market reach [10][11]. - Rongchang Biopharma's financial health is under scrutiny, with a reported net loss of 1.468 billion yuan and a rising debt-to-asset ratio of 63.88%, indicating significant financial pressure [6][7].